News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
SANDS ARTHUR T
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| SANDS ARTHUR T (President, CEO) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $18.89, valued at
$5.7M
|
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2020 |
4
| SANDS ARTHUR T (President, CEO) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 804,170 options to buy
@ $26.91, valued at
$21.6M
|
|
| 07/23/2020 |
3
| SANDS ARTHUR T (President, CEO) has filed a Form 3 on Nurix Therapeutics, Inc. |
| 03/03/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2013 |
4
| SANDS ARTHUR T (President & CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 20,034 shares
@ $1.98, valued at
$39.7k
Exercised 36,250 options to buy
@ $0
Exercised 37,000 options to buy
@ $0 |
|
| 02/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2012 |
4
| SANDS ARTHUR T (President & CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 9,588 shares
@ $1.78, valued at
$17.1k
Exercised 36,250 options to buy
@ $0 |
|
| 02/17/2012 |
4
| SANDS ARTHUR T (President & CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Granted 148,000 options to buy
@ $0
Granted 592,000 options to buy
@ $1.8, valued at
$1.1M
|
|
| 12/27/2011 |
4
| SANDS ARTHUR T (President & CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Exercised 58,525 options to buy
@ $1.13, valued at
$66.1k
|
|
| 02/25/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2010 |
4
| SANDS ARTHUR T (President & CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 14,872 shares
@ $1.91, valued at
$28.4k
Granted 765,000 options to buy
@ $1.9, valued at
$1.5M
Granted 73,700 options to buy
@ $0 |
|
| 08/14/2009 |
4
| SANDS ARTHUR T (Pres & CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE |
| 02/02/2007 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2006 |
SC 13G/A
| SANDS ARTHUR T reports a 5.5% stake in Lexicon Genetics Incorporated |
| 02/11/2005 |
SC 13G/A
| SANDS ARTHUR T reports a 5.7% stake in LEXICON GENETICS INCORPORATED |
| 01/21/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 02/06/2004 |
SC 13G/A
| SANDS ARTHUR T reports a 5.6% stake in LEXICON GENETICS INCORPORATED |
| 02/13/2003 |
SC 13G/A
| SANDS ARTHUR T reports a 6.3% stake in Lexicon Genetics Incorporated |
| 02/08/2002 |
SC 13G/A
| SANDS ARTHUR T reports a 5.7% stake in LEXICON GENETICS INCORPORATED |
| 02/09/2001 |
SC 13G
| SANDS ARTHUR T reports a 5.5% stake in LEXICON GENETICS INCORPORATED |
|
|